PA
SPB icon

PharVision Advisers’s Spectrum Brands SPB Stock Holding History

PharVision Advisers’s Portfolio SPB Stock Details SPB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,735
Closed -$280K – 569
2025
Q4 		$280K Sell
4,735
-1,069
-18% -$60.1K 0.14% 310
2025
Q3 		$305K Buy
+5,804
New +$322K 0.17% 216

Other funds holding SPB

Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
CCM
Callodine Capital Management Boston, Massachusetts $1.43B AUM 8.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

PharVision Advisers's SPB Position: Q1 2026 in Review

PharVision Advisers sold out of Spectrum Brands (SPB) in Q1 2026, closing a stake of 4,735 shares — an estimated $280K sold.

PharVision Advisers first reported a position in SPB in Q3 2025 and held it in 2 quarters. The position peaked at $305K in Q3 2025. 286 funds tracked by Wall St. Rank hold SPB as of Q1 2026.

  • PharVision Advisers reported no remaining Spectrum Brands position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 4,735 Spectrum Brands shares in Q1 2026, an estimated $280K.
  • PharVision Advisers first reported a position in Spectrum Brands in Q3 2025 and held it in 2 quarters.
  • PharVision Advisers's Spectrum Brands position peaked at $305K in Q3 2025.
  • 286 funds tracked by Wall St. Rank held Spectrum Brands as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.